227 related articles for article (PubMed ID: 28528544)
1. The New Chemical Reporter 6-Alkynyl-6-deoxy-GlcNAc Reveals O-GlcNAc Modification of the Apoptotic Caspases That Can Block the Cleavage/Activation of Caspase-8.
Chuh KN; Batt AR; Zaro BW; Darabedian N; Marotta NP; Brennan CK; Amirhekmat A; Pratt MR
J Am Chem Soc; 2017 Jun; 139(23):7872-7885. PubMed ID: 28528544
[TBL] [Abstract][Full Text] [Related]
2. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
Johnson B; Opimba M; Bernier J
Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
[TBL] [Abstract][Full Text] [Related]
3. Quantitative time-resolved chemoproteomics reveals that stable
Qin W; Lv P; Fan X; Quan B; Zhu Y; Qin K; Chen Y; Wang C; Chen X
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6749-E6758. PubMed ID: 28760965
[No Abstract] [Full Text] [Related]
4. Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets.
Alfaro JF; Gong CX; Monroe ME; Aldrich JT; Clauss TR; Purvine SO; Wang Z; Camp DG; Shabanowitz J; Stanley P; Hart GW; Hunt DF; Yang F; Smith RD
Proc Natl Acad Sci U S A; 2012 May; 109(19):7280-5. PubMed ID: 22517741
[TBL] [Abstract][Full Text] [Related]
5. Identification of structural and functional O-linked N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte.
Dehennaut V; Slomianny MC; Page A; Vercoutter-Edouart AS; Jessus C; Michalski JC; Vilain JP; Bodart JF; Lefebvre T
Mol Cell Proteomics; 2008 Nov; 7(11):2229-45. PubMed ID: 18617508
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
7. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
8. O-GlcNAc regulates NEDD4-1 stability via caspase-mediated pathway.
Jiang K; Bai B; Ta Y; Zhang T; Xiao Z; Wang PG; Zhang L
Biochem Biophys Res Commun; 2016 Mar; 471(4):539-44. PubMed ID: 26876577
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAc modification of GSDMD attenuates LPS-induced endothelial cells pyroptosis.
Yu F; Zhang Z; Leng Y; Chen AF
Inflamm Res; 2024 Jan; 73(1):5-17. PubMed ID: 37962578
[TBL] [Abstract][Full Text] [Related]
10. Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy.
Gurel Z; Sieg KM; Shallow KD; Sorenson CM; Sheibani N
Mol Vis; 2013; 19():1047-59. PubMed ID: 23734074
[TBL] [Abstract][Full Text] [Related]
11. O-GlcNAcylation site mapping by (azide-alkyne) click chemistry and mass spectrometry following intensive fractionation of skeletal muscle cells proteins.
Deracinois B; Camoin L; Lambert M; Boyer JB; Dupont E; Bastide B; Cieniewski-Bernard C
J Proteomics; 2018 Aug; 186():83-97. PubMed ID: 30016717
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Labeling for the Visualization and Identification of Potentially O-GlcNAc-Modified Proteins.
Pedowitz NJ; Zaro BW; Pratt MR
Curr Protoc Chem Biol; 2020 Jun; 12(2):e81. PubMed ID: 32289208
[TBL] [Abstract][Full Text] [Related]
13. Acute Increases in Protein O-GlcNAcylation Dampen Epileptiform Activity in Hippocampus.
Stewart LT; Khan AU; Wang K; Pizarro D; Pati S; Buckingham SC; Olsen ML; Chatham JC; McMahon LL
J Neurosci; 2017 Aug; 37(34):8207-8215. PubMed ID: 28760863
[TBL] [Abstract][Full Text] [Related]
14. Analytical and Biochemical Perspectives of Protein O-GlcNAcylation.
Ma J; Wu C; Hart GW
Chem Rev; 2021 Feb; 121(3):1513-1581. PubMed ID: 33416322
[TBL] [Abstract][Full Text] [Related]
15. Methods for the Detection, Study, and Dynamic Profiling of O-GlcNAc Glycosylation.
Thompson JW; Griffin ME; Hsieh-Wilson LC
Methods Enzymol; 2018; 598():101-135. PubMed ID: 29306432
[TBL] [Abstract][Full Text] [Related]
16. Dynamic O-linked N-acetylglucosamine modification of proteins affects stress responses and survival of mesothelial cells exposed to peritoneal dialysis fluids.
Herzog R; Bender TO; Vychytil A; Bialas K; Aufricht C; Kratochwill K
J Am Soc Nephrol; 2014 Dec; 25(12):2778-88. PubMed ID: 24854264
[TBL] [Abstract][Full Text] [Related]
17. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
Isono T
PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive mapping of O-GlcNAc modification sites using a chemically cleavable tag.
Griffin ME; Jensen EH; Mason DE; Jenkins CL; Stone SE; Peters EC; Hsieh-Wilson LC
Mol Biosyst; 2016 May; 12(6):1756-9. PubMed ID: 27063346
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease.
Levine PM; Galesic A; Balana AT; Mahul-Mellier AL; Navarro MX; De Leon CA; Lashuel HA; Pratt MR
Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1511-1519. PubMed ID: 30651314
[TBL] [Abstract][Full Text] [Related]
20. Distributive O-GlcNAcylation on the Highly Repetitive C-Terminal Domain of RNA Polymerase II.
Lu L; Fan D; Hu CW; Worth M; Ma ZX; Jiang J
Biochemistry; 2016 Feb; 55(7):1149-58. PubMed ID: 26807597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
